Stocks
Moderna (MRNA) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 76.3% | 51.8% | -47.9% | -106.1% | -131.3% | -132.9% | ||
| Changes by years, y/y, % | +164pp | -25pp | -100pp | -58pp | -25pp | +8.4% | |||
Moderna. EBITDA margin, %
Moderna. EBITDA margin, changes, pp
Moderna (MRNA) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | -535.2% | -13.3% | -108.0% | -323.4% | -562.1% | -132.9% | |
| Changes by years, y/y, % | +22pp | -18pp | +9pp | +540pp | -27pp | |||
| Changes by quarters, q/q, % | +328pp | +522pp | -95pp | -215pp | -239pp | |||
